Back to results
Key Publications March 2, 2017

Cholesterol, cardiovascular risk, statins, PCSK9 inhibitors, and the future of LDL-C Lowering.

JAMA. 2016;316:1967-1968

Rodriguez F, Harrington RA

Back to results